In February 2019, ASTHO surveyed its members to understand how data is being utilized to address these harms in their jurisdictions. This brief summarizes the results of this survey and highlights ...
Opioid and substance use disorders (SUD) continue to affect families beyond pregnancy; in 2017, about one in eight U.S. children lived in a household where at least one parent had a SUD in the prior ...
This conversation was recorded in May 2020, but felt the lessons and takeaways are still very relevant as we are finally starting to emerge from the COVID-19 pandemic. The rates of depression, ...
Initial estimates from 2020 suggest that annual drug overdose deaths in the United States reached a record high of 93,000. Fortunately EMS strategies are being put in place to combat this nation-wide ...
COVID-19 has elevated our nation’s stress level. When not managed properly (or without any buffers like social support) stress is associated with increased depression and anxiety. Because COVID-19 ...
With data showing the number of the opioid overdose deaths escalated during the COVID-19 pandemic, access to naloxone, a medication that can reverse an opioid overdose, continues to be an important ...
This report highlights six public health approaches for addressing the rising incidence of substance use disorder and neonatal abstinence syndrome and draws out the critical role that state health ...
This brief outlines some of the barriers that pregnant and postpartum women with opioid use disorder face, as well as examples of state legislation passed to address recovery program implementation, ...
State and territorial health agencies continue to be challenged by the opioid epidemic, which has been exacerbated by the COVID-19 pandemic. Addressing the opioid crisis requires a robust public ...